| DRUG WATCH |
|
| Year : 2013 | Volume
: 45
| Issue : 6 | Page : 636-637 |
Phenytoin-induced cerebellar atrophy in an epileptic boy
Nithin Kumar1, Ananya Chakraborty2, Swaroop H Suresh2, Sashidharan Basappaji3, Anand L Betdur3
1 Department of Neurology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
2 Department of Pharmacology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
3 Department of Medicine, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka, India
Correspondence Address:
Ananya Chakraborty
Department of Pharmacology, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.121388
Epilepsy is an important health problem due to its high prevalence and potential for causing long-term morbidity. It is commonly treated in children with phenytoin sodium. It has wide pharmacokinetic variability and a narrow therapeutic range that leads to toxicity. Here, we report a case of phenytoin-induced cerebellar atrophy in a 16-year-old epileptic boy who presented to the hospital with a viral infection.
[FULL TEXT] [PDF]*
|
